Attenuated HIV Vaccines

Anne-Mieke Vandamme

NULL

*Correspondence: Anne-Mieke Vandamme, Email not available

Abstract

After 14 to 18 years of infection, half of the survivingpatients in an Australian cohort infected withHIV-1 carrying natural deletions in Nef are showingCD4 cell decline and viral load rise (Learmont et al.NEJM 1999;340:1715-22). Thus, although highlyattenuated, Nef-deleted or-mutated viruses are unsuitableas vaccine strains. Johnson et al. (J Virol1999;73:4952) showed that the degree of protectionby even further attenuated SIV strains, carryingdeletions in Nef, Vpr, Vpx and/or the U3 (LTR) region,against challenge with intact SIV was inverselyrelated to the extend of attenuation. Animals infectedwith virus carrying deletions in Nef, U3 andVpr were all protected against superinfection.

Contents

DOI not available
    DOI not available